抗人EGFR/抗CD3双功能抗体治疗胰腺癌的实验研究

doi:10.6040/j.issn.1671-7554.0.2012.566

山东大学学报（医学版） ›› 2014, Vol. 52 ›› Issue (1): 15-19.doi: 10.6040/j.issn.1671-7554.0.2012.566

抗人EGFR/抗CD3双功能抗体治疗胰腺癌的实验研究

张林1，侯艳红1，张健2，胡静1，张静1

1.解放军第309医院消化内科，北京 100091； 2.解放军第四军医大学分子生物学教研室，西安 710032

收稿日期:2012-08-20 出版日期:2014-01-10 发布日期:2014-01-10
通讯作者: 张林， E-mail:stepinghuns2@yahoo.cn

Experimental study of anti-CD3/anti-EGFR bispecific antibody therapeutic activity against pancreatic cancer cells

ZHANG Lin1, HOU Yan-hong1, ZHANG Jian2, HU Jing1, ZHANG Jing1

1. Department of Gastroenterology, the 309th Hospital of PLA, Beijing 100091, China;
2. Department of Molecular Biology, the Fourth Military Medical University, Xi’an 710032, China;

Received:2012-08-20 Online:2014-01-10 Published:2014-01-10

摘要/Abstract

摘要：

目的初步验证化学偶联法合成的EGFR/CD3双功能抗体在体外对胰腺癌细胞的杀伤作用。方法在前期化学偶联法合成EGFR/CD3双功能抗体的基础上,进行效应细胞及靶细胞结合率检测及51Cr杀伤实验检测，探讨其影响效应细胞与胰腺癌细胞结合及杀伤能力的作用，并与EGFR单抗比较。采用流式细胞仪检测处理后肿瘤细胞周期与凋亡情况变化。结果 EGFR/CD3双功能抗体与效应细胞(PBLS细胞)及胰腺癌细胞株SW1990结合率较高,可满足治疗需求；EGFR/CD3双功能抗体联合效应细胞对胰腺癌细胞株SW1990杀伤率显著高于各对照组(P＜0.05)。EGFR/CD3双功能抗体联合效应细胞处理后肿瘤细胞凋亡率上升。结论 EGFR/CD3双功能抗体可有效增强免疫效应细胞对胰腺癌的杀伤作用，具有潜在的临床应用价值。

关键词: 胰腺肿瘤, 双功能抗体, EGFR单克隆抗体, 细胞免疫治疗

Abstract:

Objective To investigate the cytotoxicity of EGFR/CD3 bispecific antibody by chemical synthesis against pancreatic cancer cells in vitro. Methods In previous researches, the EGFR/CD3 bispecific antibody was prepared by chemical synthesis. The cytotoxicity activity of this antibody against pancreatic cancer was analyzed by the cell combination rate assay and 51Cr assay. The cell cycle and apoptosis were analyzed by flow cytometry. Then the comparisions of the cytotoxicity activity between the bispecific antibody and EGFR mAb was conducted. Results The biding rate of EGFR/CD3 bispecific antibody cell with effector cells PBLS and pancreatic cancer cell line SW1990 was high enough to satisfy the treatment demand.The lysis rate and apoptosis rate of cancer cells treated with immunological effector cells targeted by EGFR/CD3 bispecific antibody were higher than those of the control groups significantly (P<0.05). The apoptosis rate of cancer cells increased. Conclusion It is suggested that the cytotoxicity of effector cells could be enhanced by EGFR/CD3 bispecific antibody in vitro, so it has promising curative effect on pancreatic cancer.

Key words: Cellular immunotherapy, EGFR monoclone antibody, Pancreatic neoplasms, Bispecific antibody

张林1，侯艳红1，张健2，胡静1，张静1. 抗人EGFR/抗CD3双功能抗体治疗胰腺癌的实验研究[J]. 山东大学学报（医学版）, 2014, 52(1): 15-19.

ZHANG Lin1, HOU Yan-hong1, ZHANG Jian2, HU Jing1, ZHANG Jing1. Experimental study of anti-CD3/anti-EGFR bispecific antibody therapeutic activity against pancreatic cancer cells[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(1): 15-19.

参考文献

相关文章 10

[1]	李星宇, 梁婧, 李岩. 血管内皮抑素协同肿瘤特异性DC-T细胞的抗肿瘤效应[J]. 山东大学学报（医学版）, 2015, 53(7): 19-23.
[2]	徐阳1，曲辉2，孙国瑞2，何庆泗2. 胰腺癌根治术后淋巴结总数及阴性淋巴结数与预后的相关性[J]. 山东大学学报(医学版), 2013, 51(7): 70-74.
[3]	古力巴哈尔·阿不力米题1，龚晓瑾1，古力娜尔·库尔班2. 胰腺癌组织中MMP-9、IL-6的表达及其与临床病理分型的关系[J]. 山东大学学报(医学版), 2011, 49(9): 99-.
[4]	郑洪民. 分子影像标记物叶酸受体α在胰腺癌中的表达及意义[J]. 山东大学学报(医学版), 2010, 48(3): 83-85.
[5]	. 术前减黄对胰头癌伴梗阻性黄疸患者行胰十二指肠切除术的影响[J]. 山东大学学报(医学版), 2009, 47(10): 118-121.
[6]	崔亚洲1 ，贾青2 ，王兆朋2 ，王朝霞2 ，张月英2 ，张维东2 ，韩金祥1 . 蝎毒多肽提取物抑制胰腺癌肝转移作用的实验研究[J]. 山东大学学报(医学版), 2009, 47(03): 20-22.
[7]	张红雨,费立明,王长亮,赵文华,张波,周武元,仲伟霞,李胜 . 胰腺癌Syk表达与病理分期及血管生成的相关性[J]. 山东大学学报(医学版), 2008, 46(9): 880-883.
[8]	崔亚洲,贾青,王兆朋,王朝霞,田美,张月英,张维东,韩金祥 . 裸鼠胰腺癌高肝转移模型的建立[J]. 山东大学学报(医学版), 2008, 46(8): 739-741.
[9]	董宁宁,王南达,张发学,李文海,刁玉涛,李会庆,王明玉 . 招远市1985～2004年农村人口胰腺癌死亡率变化趋势[J]. 山东大学学报(医学版), 2008, 46(10): 1007-1011.
[10]	李玉亮,王永正,王晓华,张福君,朱立东,张万明,李征,李振家,张开贤 . 动脉灌注吉西他滨联合125I粒子胰腺内植入治疗进展期胰腺癌[J]. 山东大学学报(医学版), 2007, 45(4): 393-396.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

抗人EGFR/抗CD3双功能抗体治疗胰腺癌的实验研究

Experimental study of anti-CD3/anti-EGFR bispecific antibody therapeutic activity against pancreatic cancer cells

PDF (PC)

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

多维度评价

本文评价

推荐阅读 0